NEI
Northwest & Ethical Investments Portfolio holdings
AUM $4.03B
1-Year Return
20.27%
This Quarter Return
+4.98%
1 Year Return
+20.27%
3 Year Return
+68.59%
5 Year Return
+133.3%
10 Year Return
+253.02%
AUM
$1.59B
AUM Growth
+$86M
(+5.7%)
Cap. Flow
+$14.7M
Cap. Flow
% of AUM
0.92%
Top 10 Holdings %
Top 10 Hldgs %
19.03%
Holding
383
New
26
Increased
174
Reduced
114
Closed
19
Top Buys
| 1 |
MAXR
Maxar Technologies Inc. Common Stock
MAXR
|
+$14.9M |
| 2 |
Scotiabank
BNS
|
+$7.74M |
| 3 |
Biogen
BIIB
|
+$5.37M |
| 4 |
NiSource
NI
|
+$4.17M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$3.14M |
Top Sells
| 1 |
Toronto Dominion Bank
TD
|
+$15.1M |
| 2 |
Canadian National Railway
CNI
|
+$4.9M |
| 3 |
RTX Corp
RTX
|
+$4.37M |
| 4 |
Eli Lilly
LLY
|
+$4.22M |
| 5 |
Canadian Imperial Bank of Commerce
CM
|
+$3.79M |
Sector Composition
| 1 | Financials | 22.26% |
| 2 | Industrials | 12.14% |
| 3 | Technology | 11.02% |
| 4 | Energy | 9.52% |
| 5 | Consumer Discretionary | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Banco Macro
BMA
$2.78B
| $177K | 0.01% |
4,271
+427
| +11% | +$17.7K |
|
327
PJT Partners
PJT
$4.39B
| $136K | 0.01% |
2,593
| – | – |
|
328
Centene
CNC
$15.8B
| $116K | 0.01% |
1,600
-2,000
| -56% | -$145K |
|
329
Edwards Lifesciences
EW
$44.1B
| $109K | 0.01% |
1,875
-1,200
| -39% | -$69.6K |
|
330
Humana
HUM
$32.4B
| $102K | 0.01% |
300
-400
| -57% | -$135K |
|
331
IQVIA
IQV
$31.7B
| $99.4K | 0.01% |
766
-1,100
| -59% | -$143K |
|
|
AGN
332
DELISTED
Allergan plc
AGN
| $95.2K | 0.01% |
500
-100
| -17% | -$19K |
|
333
Medtronic
MDT
$121B
| $88.5K | 0.01% |
900
-1,300
| -59% | -$128K |
|
334
Service Corp International
SCI
$11.1B
| $88.4K | 0.01% |
2,000
-1,700
| -46% | -$75.1K |
|
|
ATTO
335
DELISTED
Atento S.A.
ATTO
| $87.7K | 0.01% |
2,327
+125
| +6% | +$4.71K |
|
336
Jazz Pharmaceuticals
JAZZ
$7.7B
| $84.1K | 0.01% |
500
-300
| -38% | -$50.4K |
|
337
Cooper Companies
COO
$13B
| $83.1K | 0.01% |
1,200
-13,688
| -92% | -$948K |
|
338
JetBlue
JBLU
$1.82B
| $81.3K | 0.01% |
4,200
-3,700
| -47% | -$71.6K |
|
339
Unum
UNM
$12.6B
| $78.1K | ﹤0.01% |
2,000
-1,600
| -44% | -$62.5K |
|
340
BioMarin Pharmaceuticals
BMRN
$10.4B
| $77.6K | ﹤0.01% |
800
-400
| -33% | -$38.8K |
|
341
Acushnet Holdings
GOLF
$4.37B
| $76.8K | ﹤0.01% |
2,800
-2,300
| -45% | -$63.1K |
|
342
Thor Industries
THO
$5.57B
| $75.3K | ﹤0.01% |
900
-700
| -44% | -$58.6K |
|
343
Topgolf Callaway Brands
MODG
$1.77B
| $75.3K | ﹤0.01% |
3,100
-5,600
| -64% | -$136K |
|
344
Neurocrine Biosciences
NBIX
$13.8B
| $73.8K | ﹤0.01% |
600
-600
| -50% | -$73.8K |
|
345
Fortune Brands Innovations
FBIN
$6.98B
| $73.3K | ﹤0.01% |
1,638
-1,638
| -50% | -$73.3K |
|
346
Carlyle Group
CG
$24.2B
| $69.9K | ﹤0.01% |
+3,100
| New | +$69.9K |
|
347
Bio-Rad Laboratories Class A
BIO
$7.68B
| $62.6K | ﹤0.01% |
200
-300
| -60% | -$93.9K |
|
348
Northern Trust
NTRS
$24.6B
| $61.3K | ﹤0.01% |
600
-400
| -40% | -$40.9K |
|
|
BID
349
DELISTED
Sotheby's
BID
| $54.1K | ﹤0.01% |
1,100
-1,700
| -61% | -$83.6K |
|
|
CELG
350
DELISTED
Celgene Corp
CELG
| $53.7K | ﹤0.01% |
600
-500
| -45% | -$44.7K |
|